Lantern Pharma LTRN Q1 2026 Earnings Beat Revenue NA EPS 030 Strong Q4 Rural Recovery Faces Headwinds from Rising Costs and Monsoon Uncertainties QXO Takes Hostile Route in Pursuit of Beacon as Boardroom Dispute Escalates Jim Cramer Adopts Caution on Wynn Resorts I Gotta Hold Off for Now Blue Water Acquisition Corp III BLUW Holds Steady Near 1025 as Support Level Remains Untested Voya Global Equity Dividend and Premium Opportunity Fund IGD Edges Higher as Price Approaches Key Resistance ServiceNow NOW Gains 22 as Buyers Approach Key Resistance Zone SOPA Stock Hovers at 008 With No Price Change as Key Support and Resistance Converge